FindTrial
Sign In

A systematic review of mitochondrial transplantation therapy on ischemia reperfusion injury

A systematic review of mitochondrial transplantation therapy on ischemia reperfusion injury - A systematic review of mitochondrial transplantation therapy on ischemia reperfusion injury

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000043347
Enrollment
Unknown
Registered
2021-02-17
Start date
2021-02-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical illness

Interventions

None listed

Sponsors

Feinstein Institutes for Medical Research
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: P: Critical illness related to ischemia reperfusion injury including myocardial infarction, organ transplantation, cardiac arrest, and acute brain injury. I: Intraarterial or intravenous injection, or direct injection into the region at risk with isolated mitochondria. O: Biological or physiological measures of the ischemia reperfusion injury. S: RCT, other intervention studies, cohort studies, animal studies 1. Studies published in peer-reviewed journals. 2. Studies published as research papers which enabled to obtain a full text.

Exclusion criteria

Exclusion criteria: 1. Studies that used a mesenchymal stem cell-mediated transfer of mitochondria as a transfer method 2. Studies under cell culture conditions

Design outcomes

Primary

MeasureTime frame
Biological or physiological measures of the ischemia reperfusion injury.—

Countries

North America

Contacts

Public ContactKei Hayashida

Feinstein Institutes for Medical Research Emergency medicine

keilinda0714@gmail.com1-516-562-1305

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026